Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315.

Agilli, Mehmet

Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. [electronic resource] - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Aug 2015 - 317-8 p. digital

Publication Type: Letter

1477-092X

10.1177/1078155215585191 doi


Breast Neoplasms--diagnosis
Chemotherapy, Adjuvant--adverse effects
Female
Humans
Metabolic Syndrome--chemically induced
Risk Factors